2017Phase 1–2 human evidence
Circulating cathelicidin LL-37 in adult patients with pulmonary infectious diseases.
PubMed-indexed clinical trial; journal article examining circulating cathelicidin ll-37 in adult patients with pulmonary infectious diseases. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Karol Majewski; Paulina Żelechowska; Ewa Brzezińska-Błaszczyk
- Source
- Clinical and investigative medicine. Medecine clinique et experimentale
- DOI
- 10.25011/cim.v40i1.28052
- PubMed
- 28218580
Open original source2017Phase 1–2 human evidence
Serum level of cathelicidin LL-37 in patients with active tuberculosis and other infectious diseases.
PubMed-indexed comparative study; journal article; randomized controlled trial examining serum level of cathelicidin ll-37 in patients with active tuberculosis and other infectious diseases. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- K Majewski; J Agier; E Kozłowska; E Brzezińska-Błaszczyk
- Source
- Journal of biological regulators and homeostatic agents
- PubMed
- 28956425
Open original source2024Observational human evidence
Salivary Cathelicidin (LL-37) in Children and Adolescents Living with HIV.
PubMed-indexed journal article examining salivary cathelicidin (ll-37) in children and adolescents living with hiv. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Ana Lucia Seminario; Ashley E Karczewski; Whasun Chung; Yan Wang; Dalton Wamalwa; Sarah Benki-Nugent; Grace John-Stewart; Jennifer A Slyker; Arthur Kemoli
- Source
- Biomedicine hub
- DOI
- 10.1159/000535596
- PubMed
- 38287973
Open original source2020Observational human evidence
Cathelicidin LL-37 (an antimicrobial peptide)-induced colistin dependence in Acinetobacter baumannii.
PubMed-indexed journal article examining cathelicidin ll-37 (an antimicrobial peptide)-induced colistin dependence in acinetobacter baumannii. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Ji-Young Lee; Yoon-Kyoung Hong; Kwan Soo Ko
- Source
- Diagnostic microbiology and infectious disease
- DOI
- 10.1016/j.diagmicrobio.2019.114965
- PubMed
- 32019695
Open original source2017Observational human evidence
Cathelicidin (LL-37) and human β2-defensin levels of children with post-infectious bronchiolitis obliterans.
PubMed-indexed journal article; multicenter study examining cathelicidin (ll-37) and human β2-defensin levels of children with post-infectious bronchiolitis obliterans. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Ahmet Hakan Gedik; Erkan Cakir; Yasemin Gokdemir; Zeynep Seda Uyan; Abdurrahim Kocyigit; Emel Torun; Bulent Karadag; Refika Ersu; Fazilet Karakoc
- Source
- The clinical respiratory journal
- DOI
- 10.1111/crj.12331
- PubMed
- 26073571
Open original source2018Observational human evidence
The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections.
PubMed-indexed journal article examining the impact of cathelicidin, the human antimicrobial peptide ll-37 in urinary tract infections. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Ibrahim H Babikir; Elsir A Abugroun; Naser Eldin Bilal; Abdullah Ali Alghasham; Elmuataz Elmansi Abdalla; Ishag Adam
- Source
- BMC infectious diseases
- DOI
- 10.1126/science.282.5393.1494
- PubMed
- 29310594
Open original source2025Observational human evidence
Study of cathelicidin (LL-37) immunoexpression in the skin of vitiligo patients.
PubMed-indexed journal article examining study of cathelicidin (ll-37) immunoexpression in the skin of vitiligo patients. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Lamia Hamouda Elgarhy; Basma Ramadan Refaey Ramadan; Fersan Abd Allah Sallam; Dalya Ayman Iskandarani; El-Sayed Shaaban Hewedy
- Source
- Archives of dermatological research
- DOI
- 10.1080/09546634.2020.1757018
- PubMed
- 39873762
Open original source2016Observational human evidence
Human cathelicidin LL-37 inhibits platelet aggregation and thrombosis via Src/PI3K/Akt signaling.
PubMed-indexed journal article; research support, non-u.s. gov't examining human cathelicidin ll-37 inhibits platelet aggregation and thrombosis via src/pi3k/akt signaling. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Wen Su; Yahui Chen; Caihui Wang; Xue Ding; Gamariel Rwibasira; Yi Kong
- Source
- Biochemical and biophysical research communications
- DOI
- 10.1016/j.bbrc.2016.03.095
- PubMed
- 27012197
Open original source2023Observational human evidence
Cathelicidin LL-37 Activates Human Keratinocyte Autophagy through the P2X₇, Mechanistic Target of Rapamycin, and MAPK Pathways.
PubMed-indexed journal article; research support, non-u.s. gov't examining cathelicidin ll-37 activates human keratinocyte autophagy through the p2x₇, mechanistic target of rapamycin, and mapk pathways. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Risa Ikutama; Ge Peng; Saya Tsukamoto; Yoshie Umehara; Juan Valentin Trujillo-Paez; Hainan Yue; Hai Le Thanh Nguyen; Miho Takahashi; Shun Kageyama; Masaaki Komatsu; Ko Okumura; Hideoki Ogawa
- Source
- The Journal of investigative dermatology
- DOI
- 10.1016/j.jid.2022.10.020
- PubMed
- 36455652
Open original source2011Observational human evidence
The human cathelicidin, LL-37, induces granzyme-mediated apoptosis in cytotoxic T lymphocytes.
PubMed-indexed journal article; research support, non-u.s. gov't examining the human cathelicidin, ll-37, induces granzyme-mediated apoptosis in cytotoxic t lymphocytes. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Jamie S Mader; Marcelo Marcet-Palacios; Robert E W Hancock; R Chris Bleackley
- Source
- Experimental cell research
- DOI
- 10.1016/j.yexcr.2010.11.015
- PubMed
- 21134367
Open original source2017Observational human evidence
Serum levels of peptide cathelicidin LL-37 in elderly patients with depression.
PubMed-indexed journal article examining serum levels of peptide cathelicidin ll-37 in elderly patients with depression. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Elżbieta Kozłowska; Adam Wysokiński; Ewa Brzezińska-Błaszczyk
- Source
- Psychiatry research
- DOI
- 10.1016/j.psychres.2017.05.036
- PubMed
- 28550757
Open original source2021Observational human evidence
Cathelicidin LL-37 Ignites Primed NLRP3 Inflammasomes in Rosacea.
PubMed-indexed journal article; comment examining cathelicidin ll-37 ignites primed nlrp3 inflammasomes in rosacea. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- David O Croitoru; Vincent Piguet
- Source
- The Journal of investigative dermatology
- DOI
- 10.1016/j.jid.2021.04.024
- PubMed
- 34565561
Open original source2022Observational human evidence
Engineered Exosomes Containing Cathelicidin/LL-37 Exhibit Multiple Biological Functions.
PubMed-indexed journal article; research support, n.i.h., extramural; research support, non-u.s. gov't examining engineered exosomes containing cathelicidin/ll-37 exhibit multiple biological functions. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Yajuan Su; Navatha Shree Sharma; Johnson V John; Gitali Ganguli-Indra; Arup K Indra; Adrian F Gombart; Jingwei Xie
- Source
- Advanced healthcare materials
- DOI
- 10.1002/adhm.202200849
- PubMed
- 35930707
Open original source2017Observational human evidence
Cathelicidin (LL-37) level in the scalp hair of patients with tinea capitis.
PubMed-indexed journal article examining cathelicidin (ll-37) level in the scalp hair of patients with tinea capitis. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Nagwa H Abdelaal; Laila A Rashed; Sahar Y Ibrahim; Mona H Abd El Halim; Noha Ghoneim; Noha A Saleh; Marwah A Saleh
- Source
- Medical mycology
- DOI
- 10.1093/mmy/myw132
- PubMed
- 27915299
Open original source2020Observational human evidence
Salivary and serum cathelicidin LL-37 levels in subjects with rheumatoid arthritis and chronic periodontitis.
PubMed-indexed comparative study; journal article examining salivary and serum cathelicidin ll-37 levels in subjects with rheumatoid arthritis and chronic periodontitis. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Chia Wei Cheah; Anis Rageh Al-Maleki; Jamuna Vadivelu; Mahmoud Danaee; Sargunan Sockalingam; Nor Adinar Baharuddin; Rathna Devi Vaithilingam
- Source
- International journal of rheumatic diseases
- DOI
- 10.1111/1756-185X.13919
- PubMed
- 32743970
Open original source2024Observational human evidence
Human Cathelicidin, LL-37 a potential antiviral therapeutic for Rift Valley Fever Virus in Egypt.
PubMed-indexed journal article examining human cathelicidin, ll-37 a potential antiviral therapeutic for rift valley fever virus in egypt. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Engy M Ahmed; Abeer A Boseila; Amro S Hanora; Samar M Solyman
- Source
- Cellular and molecular biology (Noisy-le-Grand, France)
- DOI
- 10.14715/cmb/2024.70.8.1
- PubMed
- 39262269
Open original source2024Observational human evidence
Vitamin D triggers hCAP18/LL-37 production: Implications for LL-37-induced human osteoblast cytotoxicity.
PubMed-indexed journal article; research support, non-u.s. gov't examining vitamin d triggers hcap18/ll-37 production: implications for ll-37-induced human osteoblast cytotoxicity. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Alexandra Aidoukovitch; Elisabeth Bankell; Daniel Svensson; Bengt-Olof Nilsson
- Source
- Biochemical and biophysical research communications
- DOI
- 10.1016/j.bbrc.2024.149962
- PubMed
- 38642493
Open original source2021Animal research
Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model.
PubMed-indexed journal article examining efficacy of cathelicidin ll-37 in an mrsa wound infection mouse model. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Oriana Simonetti; Oscar Cirioni; Gaia Goteri; Guendalina Lucarini; Elżbieta Kamysz; Wojciech Kamysz; Fiorenza Orlando; Giulio Rizzetto; Elisa Molinelli; Gianluca Morroni; Roberto Ghiselli; Mauro Provinciali
- Source
- Antibiotics (Basel, Switzerland)
- DOI
- 10.1007/s10096-012-1663-1
- PubMed
- 34680791
Open original source2024Animal research
Cathelicidin LL-37 promotes wound healing in diabetic mice by regulating TFEB-dependent autophagy.
PubMed-indexed journal article; research support, non-u.s. gov't examining cathelicidin ll-37 promotes wound healing in diabetic mice by regulating tfeb-dependent autophagy. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Liuqing Xi; Juan Du; Wen Xue; Kan Shao; Xiaohong Jiang; Wenfang Peng; Wenyi Li; Shan Huang
- Source
- Peptides
- DOI
- 10.1016/j.peptides.2024.171183
- PubMed
- 38423213
Open original source2023Laboratory research
Cathelicidin (LL-37) causes expression of inflammatory factors in coronary artery endothelial cells of Kawasaki disease by activating TLR4-NF-κB-NLRP3 signaling.
PubMed-indexed journal article; research support, non-u.s. gov't examining cathelicidin (ll-37) causes expression of inflammatory factors in coronary artery endothelial cells of kawasaki disease by activating tlr4-nf-κb-nlrp3 signaling. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Feifei Si; Yaheng Lu; Yizhou Wen; Tingting Chen; Yingzi Zhang; Yanfeng Yang
- Source
- Immunity, inflammation and disease
- DOI
- 10.1002/iid3.1032
- PubMed
- 37773705
Open original source2011Laboratory research
Cathelicidin LL-37 peptide regulates endothelial cell stiffness and endothelial barrier permeability.
PubMed-indexed journal article; research support, n.i.h., extramural; research support, non-u.s. gov't examining cathelicidin ll-37 peptide regulates endothelial cell stiffness and endothelial barrier permeability. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Fitzroy J Byfield; Qi Wen; Katarzyna Leszczynska; Alina Kulakowska; Zbigniew Namiot; Paul A Janmey; Robert Bucki
- Source
- American journal of physiology. Cell physiology
- DOI
- 10.1152/ajpcell.00158.2010
- PubMed
- 20943960
Open original source2011Laboratory research
The human cathelicidin, LL-37, induces granzyme-mediated apoptosis in regulatory T cells.
PubMed-indexed journal article; research support, non-u.s. gov't examining the human cathelicidin, ll-37, induces granzyme-mediated apoptosis in regulatory t cells. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Jamie S Mader; Catherine Ewen; Robert E W Hancock; Robert C Bleackley
- Source
- Journal of immunotherapy (Hagerstown, Md. : 1997)
- DOI
- 10.1097/CJI.0b013e318207ecdf
- PubMed
- 21389875
Open original source2022Laboratory research
Human Cathelicidin Peptide LL-37 Induces Cell Death in Autophagy-Dysfunctional Endothelial Cells.
PubMed-indexed journal article; research support, non-u.s. gov't examining human cathelicidin peptide ll-37 induces cell death in autophagy-dysfunctional endothelial cells. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Kaori Suzuki; Mari Ohkuma; Akimasa Someya; Tomoya Mita; Isao Nagaoka
- Source
- Journal of immunology (Baltimore, Md. : 1950)
- DOI
- 10.4049/jimmunol.2100050
- PubMed
- 35387840
Open original source2016Laboratory research
Human cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cells.
PubMed-indexed journal article examining human cathelicidin, ll-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cells. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Jennifer L Harcourt; Melissa McDonald; Pavel Svoboda; Jan Pohl; Kathleen Tatti; Lia M Haynes
- Source
- BMC research notes
- DOI
- 10.1084/jem.188.10.1967
- PubMed
- 26732674
Open original source2026Laboratory research
Cathelicidin LL-37-Induced Transcriptome of Human Keratinocyte Identifies Chemokine CXCL10 Link to T-Cell-Mediated Rosacea Pathogenesis through Jak1/STAT1 Pathway.
PubMed-indexed journal article examining cathelicidin ll-37-induced transcriptome of human keratinocyte identifies chemokine cxcl10 link to t-cell-mediated rosacea pathogenesis through jak1/stat1 pathway. Machine-staged source candidate; findings and limitations require accountable review before publication.
- Authors
- Abdul W Ansari; Tanwir Habib; Fareed Ahmad; Thesni Raheed; Cynthia S Elizabeth; Sara Al-Harami; Anh Jochebeth; Martin Steinhoff
- Source
- The Journal of investigative dermatology
- DOI
- 10.1016/j.jid.2025.08.003
- PubMed
- 40835085
Open original source